RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BOLOGNA A
Collezione ASL Biella

Items : 3

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line. in British journal of cancer / Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9.

2023
AOU Città della Salute di Torino
ASL Biella

Poveda A; Tsibulak I; Wimberger P; Heinzelmann-Schwarz V; Westermann A; Aglietta M; Arcangeli V; Zamagni C; Bologna A; Benedetti Panici P; Zola P; De Giorgi U; DeCensi A; Tognon G; Rubio-Pérez MJ; Pardo B; Romeo M; Tasca G; Funari G; Iglesias M; Biagioli E; Barretina-Ginesta MP; Deryal M; Mirza MR; Fossati R; Herbertson R; Riniker S; Nyvang GB; Chekerov R; et alii...

Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study. in Scientific reports / Sci Rep. 2020 Oct 23;10(1):18190. doi: 10.1038/s41598-020-75316-x.

2020
ASL Biella

Giorda G; Pigozzi E; Loizzi V; Franzese E; Gallà V; Attademo L; Zavallone L; Orditura M; Bologna A; Casanova C; Cormio G; Pignata S; Longo L; Bergamini A; Greco F; Scarpi E; Farolfi A; Giardina D; Cioffi R; De Giorgi U;

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24). in Targeted oncology / Target Oncol. 2018 Aug;13(4):469-479. doi: 10.1007/s11523-018-0574-1.

2018
ASL Biella

Cioffi R; Pigozzi E; Giardina D; Loizzi V; Franzese E; Zavallone L; Ventriglia J; Bologna A; Orditura M; Cormio G; Longo L; Casanova C; Greco F; Gallà V; Scarpi E; Petrone M; Farolfi A; Pignata S; Giorda G; De Giorgi U;